about
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patientsStabilization of high-risk plaquesTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisRegulation of atherogenesis by chemokines and chemokine receptorsRegulation of atherogenesis by chemokine receptor CCR6The Roles of CD137 Signaling in AtherosclerosisNeointimal hyperplasia associated with synthetic hemodialysis grafts.Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient miceImbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.Cholesterol and hematopoietic stem cells: inflammatory mediators of atherosclerosis.Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation.The role of interleukin-18 in the metabolic syndrome.Influence on Adiposity and Atherogenic Lipaemia of Fatty Meals and Snacks in Daily Life.Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology.Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.The IL-33/ST2 pathway: therapeutic target and novel biomarker.Identification of candidate genes involved in coronary artery calcification by transcriptome sequencing of cell lines.Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis.Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) MiceCharacterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction.Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial.Mechanisms involved in the association between periodontal diseases and cardiovascular diseaseDifferential expression of T cell-related genes in AMI and SA stages of coronary artery disease.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Immune response to lipoproteins in atherosclerosis.Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese IndividualsSerum from exercising humans suppresses t-cell cytokine production.Cytokines and atherosclerosis: a comprehensive review of studies in miceThe downstream regulation of chemokine receptor signalling: implications for atherosclerosisThe role of the adventitia in vascular inflammation.Mast cells in vulnerable atherosclerotic plaques--a view to a kill.Platelet-lymphocyte cross-talk.T cells in arteritis and atherosclerosis.Immune and inflammatory mechanisms of atherosclerosis (*)
P2860
Q21202033-7EBD5F6B-DA09-4DBE-914C-F581290917D3Q26738584-5118758F-CCFE-4D3E-9BE2-0DCA069D7EF6Q26750725-6838C08C-A56E-4664-AE76-2FC2C987D47FQ26825467-DB3A4EC3-734C-4529-A0F9-DB87CA075684Q26996707-7CB7029F-713D-438E-A373-4899EA31BF34Q27003124-D59D55E5-1D21-4E62-A627-2496285681FBQ27023950-7419D76F-178D-48A3-9710-041C6A00850FQ28076613-C2FFF551-868F-43F0-B514-B25B4096ABF1Q30492883-27718745-2673-41E6-AC4B-DE5A1D3396F8Q30848049-1F64337A-125D-4611-A0E2-9D41E9014071Q31075609-529F5F97-2219-4EF7-90EE-62D44A6ECB2FQ31133324-8D0DFA4E-C35A-4BBF-9E77-C47EF173B9CBQ33552022-A6674125-251F-4F93-93F8-6302AC9171C4Q33773451-B9738B54-7C05-432C-A935-B5282B129DF7Q33804391-EA7C1B69-5E99-4C52-A78D-3D8167779182Q33863703-0B6DA2B0-9DE6-4A29-A93C-CC24D8C992A7Q34019117-A8A645EA-B4FA-4320-A1B6-C31DB8A34935Q34163444-FBF1A0D4-19C3-427F-9C14-9D9ABC6110D1Q34582934-5685D1DD-0341-41D8-B38D-9D66946BAD87Q34690791-1A985DF0-F7B7-40C2-9947-089EF035CF27Q34734538-9A53AE01-E461-4669-B548-22405C3496A6Q34776884-FEFA73CD-4860-469B-9B4F-55215A8F8FCFQ35120692-5D7EAD37-8D42-4733-82D6-B97363A4B5C7Q35608570-D013D177-82B6-4F1D-86DB-73054300E40DQ35707073-3C789D00-0EDA-4C9E-BAD0-09A11B7A3EBAQ35833640-E4965EFA-4D61-419C-AF2D-FD461CA7E1ACQ35951916-BC69D641-F764-407D-AD5F-B0AD33E26E90Q36026069-79F8DFFC-101D-47AE-820E-A85641A2B12DQ36046314-9E381143-C37A-477A-9D91-A9854A1C1FF4Q36079808-9A8E5B30-8508-4F03-98FA-8349D10B97F4Q36203882-6DCA3702-0A37-4765-8947-358F167D5ED0Q36339546-879C596B-1DCC-49E1-A83F-D2A3A16E6A36Q36398992-724451C5-576A-4CFB-B0D3-5D8CC336E841Q36802942-50497035-FC56-4EBF-B0C4-501281E89052Q36831073-9CC6C9E4-3E52-4FFA-B55A-10D9185D9680Q36896406-99885036-3673-40BD-A840-C2A6A2FE4364Q36924398-959B5846-0205-4BDB-B9DB-F4B98F64188DQ37058252-E3C618E6-B2EC-4F20-AA71-6082F04AC8BCQ37192834-6A56AA4B-5461-4062-A4D7-B665EDC31FF7Q37325024-7C631316-4BA0-4EA4-91FA-2A10C0F75C94
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
T cells in atherogenesis: for better or for worse?
@ast
T cells in atherogenesis: for better or for worse?
@en
type
label
T cells in atherogenesis: for better or for worse?
@ast
T cells in atherogenesis: for better or for worse?
@en
prefLabel
T cells in atherogenesis: for better or for worse?
@ast
T cells in atherogenesis: for better or for worse?
@en
P1476
T cells in atherogenesis: for better or for worse?
@en
P2093
Anna-Karin L Robertson
Göran K Hansson
P304
P356
10.1161/01.ATV.0000245830.29764.84
P407
P577
2006-09-14T00:00:00Z